Investment
Features
FeesSafety
Academy
More
Pluang+

88 Energy gets farm-out bids and maintains buy rating with a 19.8p target on Alaska oil project.

Analyst Insights
08 Oct 2026
Proactive Investors
View Source
Bullish
88 Energy gets farm-out bids and maintains buy rating with a 19.8p target on Alaska oil project.

88 Energy Ltd has received farm-out bids for its South Prudhoe acreage in Alaska and is in commercial talks, prompting broker Cavendish to keep its buy recommendation and 19.8p target price. The broker values the Augusta-1 exploration well at 22.6p per share on an unrisked basis, highlighting its potential to unlock up to 134 million barrels of oil. Drilling is planned for early 2027, pending farm-out completion, with a preferred partner expected to be chosen by mid-Q4. This development could be transformational for 88 Energy's growth prospects.

88 Energy's recent farm-out bids and broker Cavendish's buy rating provide context for energy sector activity. For readers following the energy sector, here is Pluang's market snapshot as of Oct 08, 2026 16:21 WIB: Of 38 priced US energy stocks, 29 rose and 9 fell. Notable movers include Cenovus Energy Inc (CVE) at USD 31.11 with 100% buy order activity, Exxon Mobil Corporation (XOM) at USD 166.62 with 74% buy order activity, and Solaredge Technologies Inc (SEDG) at USD 32.61 with 75% buy order activity. The most notable figure is CVE's 100% buy order activity on Pluang.

More News

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...

Market News
Bullish
37 minutes ago
Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...

Market News
Bullish
1 hour ago
Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...

Market News
Bearish
2 hours ago
Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...

Market News
Bullish
2 hours ago
U.S. XRP ETFs hold $1.7B in assets with net inflows slowing after a strong late-September surge.

U.S. XRP ETFs hold $1.7B in assets with net inflows slowing after a strong late-September surge.

U.S. spot XRP exchange-traded funds held about $1.697 billion in net assets as of October 6, with combined net inflows of $3.14 million that day. This inflow is significantly lower compared to the $75.6 million recorded during the September 21-25 wee...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App